An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
收藏DataCite Commons2025-08-12 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005570/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate endoscopic remission at Week 26 as assessed by ileocolonoscopy.
提供机构：
Vivli
创建时间：
2020-04-29
